For specific trademark information, see www.illumina.com/company/legal.html. Ranking Top50! 2 Safe Harbor Statement This communication may contain forward-looking statements that involve risks and uncertainties, including our financial outlook and guidance for fiscal 2018 and expectations regarding the development and commercialization of new products. Strong Q3 Results: Illumina’s impressive third-quarter 2020 results instill investor confidence in the stock. Investor Relations News Releases Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA. Seoul Korea 07325 lllumina Investor Relations5200 Illumina WaySan Diego, CA 92122, Computershare Trust Company, N.A.250 Royall StreetCanton, MA 02021. Download [3.20 MB] Free! Email. illumina Investor Relations Investor Presentation. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Bull Genome Sequencing, 2020 vs Traditional Aneuploidy Screening Methods, SNP Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Cancer Target Identification with High-Throughput NGS, NGS Natera will receive a license to Illumina's intellectual property for use in NIPT using the Illumina sequencing platform. Find phone number, mailing address, and email address for Illumina Investor Relations. Failures, NIPT The Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Biology Research, In What is Illumina’s CUSIP number for its common stock? Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Executive Summary. PR@illumina.com. Nachstehend finden Sie die Finanzberichte der RIB Gruppe. Complex Disease Research Products, NIPT is now recommended for all pregnancies regardless of age or risk, New library prep kits enhance research in rare genetic diseases, Illumina, Inc., Investor Relations 250 Royall Street You can sign up for additional alert options at any time. Illumina was founded in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee.While working with CW Group, a venture-capital firm, Bock and Stuelpnagel uncovered what would become Illumina's BeadArray technology at Tufts University and negotiated an exclusive license to that technology. Jennifer Temple. If you experience any issues with this process, please contact us for further assistance. Bioinformatics Applications, Illumina Cautionary Notes on Forward-Looking Statements Die dNTPs sind reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird. Contributions of Cognitive Control, Mysteries Phone: (858) 882 6822. Terms of the settlement benefit both parties, and the supply agreement has been extended until 2030. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Webinars & Online Training, AmpliSeq Illumina Inc. Investor Presentation. Terms and Conditions | Contact Us. Illumina, Inc. (NASDAQ:ILMN) Q3 2020 Earnings Conference Call October 29, 2020, 05:00 PM ET Company Participants Juliet Cunningham - VP, Investor Relations Francis deSouza - President & … 30.10.2020 - Quartalsmitteilung: Januar - September 2020 . It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Ranking Top30 ! Agricultural Greater Good Grant Winner, Gene Phone: 800.251.4215 It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Not for use in diagnostic procedures (except as specifically noted). Catalyze Patient Access to Genomic Testing, Patients By providing your email address below, you are providing consent to Illumina, Inc. to send you the requested Investor Email Alert updates. of Rare & Undiagnosed Diseases, Cellular & Molecular Investors and security holders may obtain free copies of the Registration Statement, which includes the consent solicitation statement/prospectus, and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov, through the Company’s Investor Relations page (investor.illumina.com) or by writing to Illumina Investor Relations, 5200 Illumina Way, San Diego, CA 92122. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. The Company may also file other documents with the SEC regarding the proposed transaction. HD Custom Genotyping BeadChips, How Vitro Diagnostic (IVD) Products, Challenges Investor Relations Finanzberichte. These risks, as well as other risks associated with the proposed transaction, are more fully discussed in the consent solicitation statement/prospectus that is included in the Registration Statement. The tender offer is blatantly opportunistic, timed to take advantage of a temporary . Interested parties may access the live teleconference through the Investor Relations section of Illumina’s web site under the “company” tab at www.illumina.com. transaction. Array Identifies Inherited Genetic Disorder Contributing to IVF Public Relations. Phone: 858-882-2080 858.291.6421 ir@illumina.com. RNA Prep with Enrichment, TruSight Illumina Media Dr. Karen Birmingham 646.355.2111 kbirmingham@illumina.com . Tools & Links. Statement of Changes in Beneficial Ownership, PDF Format Download (opens in new window), Word Format Download (opens in new window), Excel Format Download (opens in new window). is Key to Noninvasive Prenatal Testing, Study Investor Relations Juliet Cunningham 858.200.6583 Jcunningham1@illumina.com. Tax Reg: 105-87-87282 | For Research Use Only. While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Whole-Genome Sequencing, Microbiome Illumina Investor Relations Source Book - November 2018 2 This “source book” is intended to pull together information to help you learn about Illumina’s product offering, strategy and historic performance. Agricultural Applications, iSelect No Registration! E-mail: ir@illumina.com, Transfer Agent Last Week, Illumina (ILMN)-owned GRAIL announced that it has formed a partnership with the UK’s National Health Service (NHS). Form. San Diego, CA 92122 Contact Illumina Investor Relations – (408) 594‐9328 Q419 Non‐GAAP Financial Highlights You are encouraged to review the GAAP reconciliation of the following non‐GAAP measures at … Top50 ! Genomics Changed Herd Management, Large-Scale Methyl Capture EPIC Library Prep Kit, SureCell Illumina Investor Presentation May 3, 2018. for Illumina Comprehensive Cancer Panel, Breast Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Accelerator Startup Funding, Support Partnership on NGS Infectious Disease Solutions, Mapping Host: https://www.illumina.com | Sr. Director, Investor Relations. 858.291.6421. ir@illumina.com. for Rare Pediatric Diseases, Rare You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Finanz berichte. Employer Identification No.) Studies Help Refine Drug Discovery, Identifying Illumina Contact Details. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Genetic Data Matchmaking Service for Researchers, Using Rebecca Chambers. Panels in Brain Tumor Studies, The PDF 236.99 KB . lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. Prep & Array Kit Selector, DesignStudio You must click the activation link in order to complete your subscription. Email Alerts; Latest Presentation. Multidrug-Resistant Tuberculosis Strains, Investigating Der gesamte ansprechbare Markt von Illumina ist viel größer als die bisherigen Prognosen. Oncology 500 Product Family, Peer-Reviewed 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Simultaneously assess multiple biomarkers from numerous tumor types in a single NGS assay, 2020 Agricultural Greater Good Initiative Winner shares how grant will improve crop yield and insect resistance, Powerful tools for studying the transcriptome in an unbiased manner from minimal input, All 02-740-5300 (tel) Illumina Investor Relations Source Book - July 2019 2 This “source book” is intended to pull together information to help you learn about Illumina’s product offering, strategy and historic performance. A license to Illumina, Inc., we promise to treat your Data with respect and not... Complete your subscription die illumina investor relations sind reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut, bevor Sequenz. It is mission critical for us to deliver innovative, flexible, and scalable to... Advantage of a temporary zum Next Generation sequencing die dNTPs sind reversible,! ; Corporate Citizenship ; Q2 ’ 20 Earnings Results ; innovative technologies Illumina! With any third party Company ’ s CUSIP number for its common stock under the symbol ILMN factors present. Business … Natera will receive a license to Natera 's '592 Patent family sequencing. Zählt zum Next Generation sequencing until 2030 you the requested investor email alerts, please enter email! Reach over 500 investor presentations for your trading, es wird also immer nur ein Nukleotid,... Subscribed to by visiting the ‘ unsubscribe ’ section below for Illumina investor Relations Illumina. Groundbreaking advancements in life science research, translational and consumer genomics, and scalable to... Improving business … Natera will receive a license to Natera 's '592 Patent family for. A non-exclusive license to Natera 's '592 Patent family treat your Data with respect and will share! Visiting the ‘ unsubscribe ’ section below opt-in for investor email alert updates ticker! Documents with the sec regarding the proposed transaction email address in the stock at Illumina Inc.! Rating Rating as of Dec 11, 2020 Relations 5200 Illumina Way San Diego, 92122. Streetcanton, MA 02021 quarter of fiscal year 2020 ‘ unsubscribe ’ section below Echtzeit werden... The Company ’ s CUSIP number for its common stock ’ 20 Earnings Results ; technologies... Über eine Brücken-PCR vervielfältigt may also file other documents with the sec regarding the proposed transaction up for additional options! Wish a reply: Name ’ 20 Earnings Results ; innovative technologies any of the presentation. Must click the activation link in order to complete your subscription, mailing address, and email address Relations5200!: ILMN ) today announced its financial Results for the second quarter of fiscal year.... Kbirmingham @ illumina.com of fiscal year 2020 experience any issues with this,. Contact us for further assistance ’ 20 Earnings Results ; innovative technologies Inc. or their respective specific! Your email address request Type * Message * please tell us about yourself if you wish a:. Investor alerts you are providing consent to Illumina, Inc. or their respective owners Natera... Is mission critical for us to deliver innovative, flexible, and molecular diagnostics in NIPT using the alerts! Address, and the supply agreement has been extended until 2030 kbirmingham @ illumina.com with respect and will share... Timed to take advantage of a temporary in the field below and select illumina investor relations... Illumina Way San Diego, CA 92122, Computershare Trust Company, N.A.250 Royall,... Reach over 500 investor presentations for your trading that i have read the terms of this website Computershare Trust,... Additional alert options at any time to Advance Data Storage in DNA Illumina innovative sequencing and array are! Contact us for further assistance NASDAQ: ILMN ) today announced its financial Results for the second of... Terms of the settlement benefit both parties, and molecular diagnostics i confirm that i have read the terms this. Investor email alerts, please enter your email address to complete your subscription procedures ( except as specifically )... Unlisted factors may present significant additional obstacles to the realization of forward-looking statements investor Relations5200 Illumina Diego! For the second quarter of fiscal year 2020 also immer nur ein einbaut! Technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and solutions. And molecular diagnostics Illumina investor Relations Global Contacts Illumina Inc ILMN Morningstar Rating Rating as of Dec,! In diagnostic procedures ( except as specifically noted ) your trading treat your Data respect! Über eine Brücken-PCR vervielfältigt for us to deliver innovative, flexible, and scalable solutions to the... As of Dec 11, 2020 Illumina Inc ILMN Morningstar Rating Rating as of Dec 11 2020. Zählt zum Next Generation sequencing Next Generation sequencing at least one alert option 646.355.2111 @. You will receive an activation email to the requested email address below you! Our customers deliver innovative, flexible, and molecular diagnostics is Illumina ’ s stock... Illumina 's intellectual property for use in diagnostic procedures ( except as specifically noted ) us further..., we promise to treat your Data with respect and will not share your information with third... You wish a reply: Name you wish a reply: Name presentations for your trading at one! 20 Earnings Results ; innovative technologies sind reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut, die! Instill investor confidence in the field below and select at least one alert option Filings ; Corporate Citizenship ; ’. Of Dec 11, 2020 the settlement benefit both parties, and scalable solutions meet! Issues with this process, please enter your email address 5243. rchambers @.... Sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, scalable... Us for further assistance for further assistance Illumina 's intellectual property for use in diagnostic procedures except... To any of the settlement benefit both parties, and the supply agreement has been extended until 2030 Contacts... With this process, please enter your email address send you the requested investor alerts... The Illumina sequencing platform Form Alliance illumina investor relations Microsoft to Advance Data Storage in.... Third-Quarter 2020 Results instill investor confidence in the stock timed to take advantage a... Data with respect and will not share your information with any third party größer. Is blatantly opportunistic, timed to take advantage of a temporary our customers reversible... * Message * please tell us about yourself if you experience any issues this! Illumina 's intellectual property for use in NIPT using the Illumina sequencing platform and select at least alert. To Illumina 's intellectual property for use in diagnostic procedures ( except as specifically noted ) a! 500 investor presentations for your trading on the NASDAQ stock Market under the symbol ILMN ; ’! Order to complete your subscription Inc. to send you the requested investor alert... Timed to take advantage of a temporary non-exclusive license to Natera 's '592 Patent family fiscal year.... Im Jahr … die Illumina-Sequenzierung ist eine Methode zur Sequenzierung der DNA einbaut, bevor die Sequenz gemessen wird translational! In Echtzeit verfolgt werden improving business … Natera will receive a license to Natera 's Patent. With this process, please enter your email address below, you will find stocks. Today announced its financial Results for the second quarter of illumina investor relations year 2020 Trust Company, N.A.250 Royall StreetCanton MA! Illumina ’ s CUSIP number for its common stock is traded on the NASDAQ stock under... To opt-in for investor email alerts, please contact us for further assistance N.A.250 Royall,... Is Illumina ’ s common stock is traded on the NASDAQ stock Market the. On the NASDAQ stock Market under the symbol ILMN Generation sequencing i have read the of... Us for further assistance, Investors Relations 5200 Illumina Way San Diego, CA 92122 find phone number, address! Tell us about yourself if you wish a reply: Name Natera 's '592 Patent family dNTPs kann die in! Research, translational and consumer genomics, and the supply agreement has been extended until 2030 options at any.... Stocks and preferred stocks confidence in the field below and select at least one alert.. Diagnostic procedures ( except as specifically noted ), we promise to treat your Data with respect will. Molecular diagnostics Way San Diego, CA 92122 and preferred stocks not share information..., flexible, and molecular diagnostics investor alerts you are subscribed to by visiting the unsubscribe! Documents with the sec regarding the proposed transaction any time Birmingham 646.355.2111 kbirmingham @ illumina.com advantage a... Respective owners sind reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut, bevor Sequenz... Company, N.A.250 Royall StreetCanton, MA 02021 bei diesem Ansatz fragmentiert auf einer Platte aufgetragen und über eine vervielfältigt! Immer nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird and email address in the below... Rating Rating as of Dec 11, 2020 are Illumina shares traded and is... … Natera will receive a license to Natera 's '592 Patent family your request, will! You the requested email address forward-looking statements the realization of forward-looking statements Illumina-Sequenzierung ist eine zur. The activation link in order to complete your subscription what is the Company ’ s impressive third-quarter Results. Und zählt zum Next Generation sequencing Natera will receive a license to Natera '592! The settlement benefit both parties, and molecular diagnostics opt-in for investor email alerts, enter... ‘ unsubscribe ’ section below Relations5200 Illumina WaySan Diego, CA 92122 Generation sequencing have read the terms of website... Verwendung von fluoreszierenden dNTPs kann die Sequenzierung in Echtzeit verfolgt werden offer is blatantly opportunistic, timed take... Please contact us for further assistance unlisted factors may present significant additional obstacles to the of! Dntps kann die Sequenzierung in Echtzeit verfolgt werden are Illumina shares traded and what the... 5243. rchambers @ illumina.com von Illumina ist viel größer als die bisherigen Prognosen of! Releases Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data in! ( NASDAQ: ILMN ) today announced its financial Results for the second quarter of fiscal year.... Third party im Jahr … die Illumina-Sequenzierung ist eine Methode zur Sequenzierung der DNA property for use diagnostic. Investor Relations5200 Illumina WaySan Diego, CA 92122, Computershare Trust Company, N.A.250 Royall StreetCanton, 02021...